niraparib 100 mg (Zejula 100 mg)
Generic Name: niraparib
Pill with imprint niraparib 100 mg is Purple / White, Capsule-shape and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc..
Zejula is used in the treatment of ovarian cancer; peritoneal cancer; fallopian tube cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for niraparib 100 mg
Zejula
- Generic Name:
- niraparib
- Imprint:
- niraparib 100 mg
- Strength:
- 100 mg
- Color:
- Purple / White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- PARP inhibitors
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Tesaro Inc.
- National Drug Code (NDC):
- 69656-0103
More about Zejula (niraparib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: PARP inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
